Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial
-
Xeriant Sets Up Next Production Run of NEXBOARD™ Following Class A Fire Rating and NFPA 286 Fire Testing Certification
-
Take 5 Oil Change Opens New Location in Colorado Springs
-
Outdoor Holding Company Reports Fourth Quarter and Fiscal Year 2026 Financial Results
-
Verrica Pharmaceuticals Announces First U.S. Patient Dosed in the Second Pivotal Clinical Trial (COVE-3) of its Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts
-
Edmonton father of two wins $1 million after moving savings to Servus
-
Firm Capital Property Trust Announces Completion of Competition Bureau of Canada Inquiry Regarding Acquisition of 50% Interests in Ten Manufactured Home Communities for $218 Million
-
MAX Power Appoints Chad Levesque as President and New Board Director as Company Advances Toward Commercialization of Natural Hydrogen
-
Early Warning Press Release
-
Hexagon Bio Announces Formation of Clinical Advisory Board of Renowned Breast Cancer Experts to Support Development of HEX-360, a Next-Generation HER2-Targeting ADC
-
Evolve Royalties Announces DTC Eligibility
-
GoGo AI Network Inc. and Algo8 Industrial AI Inc. Announce Definitive Arrangement Agreement to Spin Out Full-Stack Industrial AI Platform to Public Markets
-
Nasus Pharma to Participate in the Zacks Life Sciences Investor Forum
-
Novel Key Terms For Managing CIDP Published in Neurology® Journal
-
Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Elsunersen for the Treatment of Seizures Associated with SCN2A Developmental and Epileptic Encephalopathy Caused by Gain of
-
GuideAI Health Receives FDA 510(k) Clearance for VascularAssist Occlusion Triage
-
Revolution Medicines Announces Planned Leadership Transition for Steve Kelsey, M.D.
-
Skyborne Technology, Inc (STI), a UAV Corp Company, completes initial step for Weight Balance Analysis and Flight Testing
-
MADD Canada Urges Quebecers to Celebrate Saint-Jean-Baptiste Day Responsibly
-
Prolium Bioscience Announces First Patient Dosed in its Multinational, Phase 1/2 Study of PRO-203 in Systemic Sclerosis, and Last Patient, Last Visit in an Investigator-Led Study of PRO-203 in Refract
-
Azure Maps Gen1 Pricing Customers To Be Migrated To Gen2 Pricing in September 2026, A 9x Cost Increase
-
LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection
-
Aptorum Group Announces Collaboration between DiamiR Biosciences and AlzLabs Precision Diagnostics for Alzheimer’s Disease Biomarkers
-
Genius Group Buys Back 6,037,851 Company Shares
-
NorthStar Secures Over CAD$40M with 3 Canadian Space Division to Advance Sovereign Space Domain Awareness
-
Rezolve Ai Powers New Mashreq and Visa Everyday Cashback Program, Bringing AI-Enabled Card Linked Offers to UAE Cardholders
-
Country Stampede Breaks Attendance Records
-
BitFuFu Announces US$5 Million Share Repurchase Program
-
Tyson® Debuts New Garlic & Herb, BBQ, and Harissa Chicken Cups
-
Veea Strengthens Executive Leadership Team to Accelerate its Commercial Growth and Market Expansion
-
Kandi Technologies Accelerates Global Expansion
-
Route 92 Medical Announces First Commercial Cases in Canada
-
Westport Announces US$10 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
-
Catheter Precision, Inc. Announces Allowance of Key Intellectual Property
-
Atsena Therapeutics Doses First Patient and Reports Rapid Early Enrollment in Pivotal Trial of ATSN-201 for X-Linked Retinoschisis
-
Upexi, Inc. Announces Pricing of ~$19.5 Million Private Placement of Common Stock
-
Amaero Expands Powder Capacity Ahead of Schedule
-
Sonoco To Report Second Quarter 2026 Results
-
Banks Deny. We Defy.™ New Federal Reserve Data Confirms the Funding Gap Crushing Small Businesses, and CredFin Is Helping Thousands Fight Back
-
BiggerPockets Appoints Active Real Estate Investor Eric Augustyn as CEO, Ushering in a New Era of Platform Innovation
-
Taysha Gene Therapies Announces Completion of Dosing in REVEAL Pivotal Trial and Reports Longer-Term Clinical Data from Part A of REVEAL Phase 1/2 Trials Evaluating TSHA-102 for Rett Syndrome
-
Prime Medicine Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
-
Hyperion DeFi and Blockdaemon Partner to Expand Institutional Hyperliquid Staking Infrastructure
-
Autonomix Medical Announces Standalone Neural Sensing Program with Evidence of Real-Time Renal Nerve Activity Change
-
GrowGeneration to Present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 on June 23, 2026
-
Lifetime Brands, Inc. Announces Results of 2026 Annual Meeting
-
DaySavers Launches Perfect Pack 2 Portable Joint-Filling Machine to Create Perfect Pre-Rolls On the Go
-
Kyverna Therapeutics Appoints Ritesh Srivastava as Chief Legal and Compliance Officer, Adding Leadership Strength to Support Commercial-Stage Transition
-
Medidata Unveils New Academic Board to Bridge the Gap Between Research and Patient Care
-
EagleNXT Secures Order of eBee VISION ISR and eBee TAC Systems from Asia Pacific Customer
